Serious Adverse Events (SAEs)/Serious Unexpected Adverse Drug Reaction (SUADR) Guidance and Report Form sae_reporting_form_2022sep.docx
21 - MGH - Q3 and Q4 Broader Public Sector Expenses Directive - Combined Summary 21 - MGH - Q3 and Q4 Broader Public Sector Expenses Directive - Combined Summary
4.1 F22 - Annual BPS Attestation (Published) May 2022 4.1_f22_-_annual_bps_attestation_published_may_2022_2.pdf
Expense Report - Q1-Q2 April 1 - Sepember 30, 2020 Expense Report - Q1-Q2 April 1 - Sepember 30, 2020
